Sofiva Genomics Co.,Ltd. (TPEX:6615)
Taiwan · Delayed Price · Currency is TWD 33.65
0.00 (0.00%)
Aug 17, 2026, 10:58 AM CST
Sofiva Genomics Market Cap
Sofiva Genomics has a market cap or net worth of 726.62 million as of August 18, 2026. Its market cap has increased by 9.25% in one year.
Market Cap
726.62M
Enterprise Value
633.14M
Revenue
379.21M
Ranking
n/a
PE Ratio
51.29
Stock Price
33.65
ChartMarket Cap Chart
Since January 5, 2017, Sofiva Genomics's market cap has decreased from 1.70B to 726.62M, a decrease of -57.23%. That is a compound annual growth rate of -8.45%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 17, 2026 | 726.62M | 11.61% |
| Dec 31, 2025 | 651.04M | -24.53% |
| Dec 31, 2024 | 862.66M | -1.51% |
| Dec 29, 2023 | 875.86M | 11.72% |
| Dec 30, 2022 | 784.00M | -24.75% |
| Dec 30, 2021 | 1.04B | -4.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jan 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BIONET | 3.09B |
| DIVA Laboratories | 1.94B |
| Puriblood Medical | 1.11B |
| Genetics Generation Advancement | 1.07B |
| Kim Forest Enterprise | 775.93M |
| TFBS Bioscience | 686.55M |
| Welgene Biotech | 390.35M |
| Pharmigene | 371.42M |